IMB's latest news, explainers and more

 


Electric caterpillar sparks new venom discoveries

Read more

Get the latest research to your inbox

Subscribe
 

Imagine waking up every day wondering if you are going to have a 'good' or 'bad' pain day. That is the reality of more than 1 in 5 Australians who live with chronic pain. But what is chronic pain and how can we treat it?
  • The future of medicine could be as simple as nibbling a sunflower seed or drinking a cup of tea, with the opening of a new IMB facility, officially opened the Hon Annastacia Palaszczuk, Queensland Premier and Minister for the Arts.
  • In a world-first, researchers from UQ IMB and University of Washington (UW) have produced tailor-made peptides – an advance expected to help improve drug design and environmentally-friendly pesticides. The team has designed ultra-stable peptide scaffolds that can be used in a range of biotechnological applications.
  • Does genetic susceptibility predispose women to postpartum depression? Researchers from UQ are calling on Australian mothers to help them find out.
  • Congratulations to IMB’s Dr Markus Muttenthaler who received the Miklós Bodanszky Award for his outstanding contributions to peptide science. 
  • Thanks to a $1.3 million state government research grant, IMB’s Dr Nathan Palpant has partnered with Professor John Fraser at The Prince Charles Hospital to develop next generation medical treatments to tackle heart disease, which claims the life of one Australian every 12 minutes.
  • Paralympian Chris Bond was 19 when a severe bacterial infection in his bowel spread through his body and sent him into septic shock. Today, on World Sepsis Day (13 September), Chris is working with IMB's Community for Open Antimicrobial Drug Discovery (CO-ADD) to bring attention to the multidrug-resistant bacteria that nearly took his life.
  • Inflazome Ltd, a company founded on research from The University of Queensland (UQ) and Trinity College Dublin, has closed a Series A financing round of up to €15 million (A$22 million).
  • IMB’s Mathilde Desselle has won the Queensland Women in Technology (WiT) InfoTech Professional Award for her leadership of biomedical research programs and facilities in the fields of genomics, bioinformatics and drug discovery.
  • IMB research could lead to a new treatment for Parkinson’s disease, with future potential applications to nearly 50 other disorders.

Pages

Strawberry DNA extraction activity

Extract and view DNA from a strawberry using common household ingredients.

Get started

 

The Edge: Infection

The latest research and discovery

We are tackling the problem of drug-resistant bacteria through developing new diagnostics and treatments, and by empowering the community with knowledge on how to fight back against the threat of superbugs.

 View the latest issue
 Download magazine

Do a PhD at IMB

Apply for the Global Challenges PhD Scholarship


We are training the next generation of researchers to tackle some of the most pressing global issues of our time.
Apply for the Domestic round and boost your stipend with our IMB Global Challenges Scholarship.
 

This year's theme is 'Drugs inspired by nature' where you can look to the world around us to develop new medicines.
Learn from the best see what you can achieve.

Find out more

Subscribe to our newsletter

Get the latest research straight to your inbox. 
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.

Subscribe

General enquiries

  +61 7 3346 2222
  imb@imb.uq.edu.au

Media enquiries

IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.

Support us

Donate to research
100% of donations go to the cause